Netflix
NFLX
Oracle
ORCL
NVIDIA
NVDA
Microsoft
MSFT
Taiwan Semiconductor
TSM
US Stock MarketDetailed Quotes
VIRX Viracta Therapeutics
- 0.164
- -0.003-1.92%
Trading Jan 22 12:29 ET
6.50MMarket Cap-0.15P/E (TTM)
0.170High0.161Low149.83KVolume0.162Open0.167Pre Close24.75KTurnover0.52%Turnover RatioLossP/E (Static)39.74MShares1.31052wk High-0.98P/B4.69MFloat Cap0.13252wk Low--Dividend TTM28.69MShs Float9324.000Historical High--Div YieldTTM5.58%Amplitude0.132Historical Low0.165Avg Price1Lot Size
About Viracta Therapeutics Company
Viracta Therapeutics, Inc. a clinical-stage, biomarker-directed precision oncology company focused on new medicines for the treatment of virus-associated malignancies. It develops antiviral agent valganciclovir as an oral combination therapy which is in a Phase 2 clinical trial for EBV-positive lymphomas. The company was founded on February 10, 1998 and is headquartered in Cardiff, CA.
Company Profile
SymbolVIRX
Company NameViracta Therapeutics
Listing DateSep 27, 2005
Issue Price7.00
Founded1998
CEOMr. Mark Andrew Rothera
MarketNASDAQ
Employees40
Fiscal Year Ends12-31
Address2533 South Coast Highway 101,Suite 210
CityCardiff
ProvinceCalifornia
CountryUnited States of America
Zip Code92007
Phone1-858-400-8470
Websitehttp://www.viracta.com
Company Executives
- Name
- Position
- Salary
- Mark Andrew Rothera
- Chief Executive Officer, President and Director
- 1.46M
- Dr. Darrel P. Cohen, M.D.,PhD
- Chief Medical Officer
- 756.73K
- Michael E. Faerm
- Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Melody Burcar
- Senior Vice President, Finance
- --
- Dr. Roger J. Pomerantz, F.A.C.P.,M.D.
- Chairman of the Board
- 210.27K
- Dr. Ivor Royston, M.D.
- Director
- 90.76K
- Dr. Flavia Borellini, PhD
- Independent Director
- 92.36K
- Thomas E. Darcy
- Independent Director
- 113.26K
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.